Recent studies have found that increased CD103+ tissue-resident CD8+ T cells are associated with improved survival in melanoma 8, lung cancer 15, and cervical cancer 16, suggesting that CD103+ T cells are a potential predictive biomarker. This evidence concerns the gene ITGAE and cervical carcinoma.